Naris Nilubol

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study
    Naris Nilubol
    Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, 10 Center Drive, Rm 3 5840, Bethesda, MD, 20892, USA
    World J Surg 40:697-705. 2016
  2. doi request reprint Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure
    Naris Nilubol
    Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Ann Surg Oncol 23:416-23. 2016
  3. pmc Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin
    Naris Nilubol
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Thyroid 23:695-702. 2013
  4. doi request reprint Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy
    Naris Nilubol
    Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, MSC1201 Room 3 3940, Bethesda, MD 20892 1201, USA
    World J Surg 37:1966-72. 2013
  5. pmc Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening
    Naris Nilubol
    Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, 10 Center Drive, MSC 1201, Bethesda, MD 20892, USA
    J Transl Med 10:198. 2012
  6. doi request reprint Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit?
    Naris Nilubol
    Endocrine Oncology Section, Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, MSC1201 Rm 3 3940, Bethesda, MD 20892 1201, USA
    World J Surg 36:1368-74. 2012
  7. doi request reprint Molecular pathways associated with mortality in papillary thyroid cancer
    Naris Nilubol
    Endocrine Oncology Section, Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA
    Surgery 150:1023-31. 2011
  8. pmc Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1
    Allison B Weisbrod
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Clin Endocrinol Metab 98:E109-14. 2013
  9. pmc Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von hippel-lindau-associated pancreatic lesions
    Samira M Sadowski
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md Electronic address
    J Am Coll Surg 218:997-1003. 2014
  10. pmc MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors
    Dhaval Patel
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md Electronic address
    Surgery 154:1224-8; discussion 1229. 2013

Collaborators

Detail Information

Publications46

  1. doi request reprint Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study
    Naris Nilubol
    Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, 10 Center Drive, Rm 3 5840, Bethesda, MD, 20892, USA
    World J Surg 40:697-705. 2016
    ..The objective of this study was to study the effect of lymphadenectomy on the survival rates of patients with ACC...
  2. doi request reprint Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure
    Naris Nilubol
    Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Ann Surg Oncol 23:416-23. 2016
    ..This study aimed to evaluate the outcome for MEN1 patients who underwent limited parathyroidectomy compared with subtotal parathyroidectomy...
  3. pmc Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin
    Naris Nilubol
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Thyroid 23:695-702. 2013
    ..Thus, using a large population-based database, we sought to better characterize the role of sex in disease aggressiveness and outcome...
  4. doi request reprint Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy
    Naris Nilubol
    Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, MSC1201 Room 3 3940, Bethesda, MD 20892 1201, USA
    World J Surg 37:1966-72. 2013
    ..Intraoperative parathyroid hormone monitoring (IOPTH) is a widely used adjunct for primary hyperparathyroidism (pHPT). However, the benefit of IOPTH in familial pHPT, such as in multiple endocrine neoplasia type I (MEN1), remains unclear...
  5. pmc Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening
    Naris Nilubol
    Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, 10 Center Drive, MSC 1201, Bethesda, MD 20892, USA
    J Transl Med 10:198. 2012
    ..The objective of this study was to identify and validate drugs with antineoplastic effect in ACC cells using a novel quantitative high-throughput drug screening (qHTS) technique...
  6. doi request reprint Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit?
    Naris Nilubol
    Endocrine Oncology Section, Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, MSC1201 Rm 3 3940, Bethesda, MD 20892 1201, USA
    World J Surg 36:1368-74. 2012
    ..The objective of the present study was to evaluate the utility of preoperative localizing studies in patients with MEN1 undergoing initial bilateral neck exploration (BNE) and parathyroidectomy for pHPT...
  7. doi request reprint Molecular pathways associated with mortality in papillary thyroid cancer
    Naris Nilubol
    Endocrine Oncology Section, Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA
    Surgery 150:1023-31. 2011
    ..Our objectives were to identify molecular pathways associated with unfavorable features and outcomes in patients with PTC...
  8. pmc Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1
    Allison B Weisbrod
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Clin Endocrinol Metab 98:E109-14. 2013
    ..We recently reported an association between O blood type and the manifestation of pancreatic neuroendocrine tumors in a cohort of patients with Von Hippel-Lindau syndrome...
  9. pmc Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von hippel-lindau-associated pancreatic lesions
    Samira M Sadowski
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md Electronic address
    J Am Coll Surg 218:997-1003. 2014
    ..The aim of this study was to determine whether 18-fluorodeoxyglucose-positron emission tomography ((18)FDG-PET) uptake predicts growth and detects malignant VHL-associated PNENs...
  10. pmc MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors
    Dhaval Patel
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md Electronic address
    Surgery 154:1224-8; discussion 1229. 2013
    ..The objective of this study was to determine the feasibility and diagnostic accuracy of measuring serum miRNAs in patients with benign and malignant adrenocortical neoplasms...
  11. pmc Genome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotype
    Ryan J Ellis
    Endocrine Oncology Branch R J E, M B, D P, N N, M H, L Z, E K, Genetics Branch Y W, H S S, S D, D C E, P S M, and Laboratory of Pathology M J M, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 and Perelman School of Medicine R J E, University of Pennsylvania, Philadelphia, Pennsylvania 19104
    J Clin Endocrinol Metab 99:E329-37. 2014
    ..Aberrant DNA methylation is known to be a major factor in oncogenesis and cancer progression, but effects of methylation in papillary thyroid cancer (PTC) are not well defined...
  12. pmc Sleeping parathyroid tumor: rapid hyperfunction after removal of the dominant tumor
    Sahzene Yavuz
    Diabetes, Endocrine and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Clin Endocrinol Metab 97:1834-41. 2012
    ..A fall of intraoperative serum PTH by a certain percentage during parathyroid surgery is often used as one criterion for ending the operation...
  13. pmc Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome
    Allison B Weisbrod
    Endocrine Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Clinical Research Center, Building 10 CRC, Room 3 3940, 10 Center Drive, MSC 1201, Bethesda, Maryland 20892, USA
    J Clin Endocrinol Metab 97:E613-7. 2012
    ..There are limited data on the clinical utility of using ¹⁸F-FDOPA PET for identifying neuroendocrine tumors in a high-risk population such as VHL...
  14. pmc Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism
    Allison B Weisbrod
    Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Ann Surg Oncol 20:753-8. 2013
    ..The goal of this study was to compare the presentation and outcome among patients undergoing adrenalectomy and found to have different histologic features...
  15. doi request reprint Feasibility of Radio-Guided Surgery with (68)Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors
    Samira M Sadowski
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Ann Surg Oncol 22:676-82. 2015
    ..The study aim was to determine the feasibility of radio-guided surgery (RGS) using (68)Ga-DOTATATE in patients with primary and recurrent GEPNETs...
  16. doi request reprint miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3
    Myriem Boufraqech
    Endocrine Oncology BranchLaboratory of PathologyNational Cancer Institute, National Institutes of Health, Center for Cancer Research, Bethesda, Maryland 20892, USA
    Endocr Relat Cancer 21:517-31. 2014
    ....
  17. pmc Rate of clinically significant postoperative pancreatic fistula in pancreatic neuroendocrine tumors
    Suzanne M Inchauste
    Endocrine Oncology Section, Surgery Branch, Center for Cancer Research, National Cancer Institute, 10 Center Drive, MSC1201 Rm 4W 5940, Bethesda, MD 20892 1201, USA
    World J Surg 36:1517-26. 2012
    ..The authors sought to determine the rate of POPF after enucleation and/or resection of pancreatic neuroendocrine tumors (PNET) and to identify clinical, surgical, or pathologic factors associated with POPF...
  18. pmc Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer
    Mei He
    Endocrine Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA
    Thyroid 23:301-7. 2013
    ..Thus, the aim of this study was to determine whether telomere length and genes involved in maintaining telomere length are altered in FNMTC...
  19. pmc von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms
    Simon Turcotte
    Endocrine Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda 20892, MD, USA
    Surgery 152:1106-17. 2012
    ..Solid microcystic serous adenoma (SMSA), a rare neoplasm described in VHL patients, can be mistaken for PNEN on imaging...
  20. doi request reprint Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites
    Samira M Sadowski
    All authors National Institutes of Health, Bethesda, MD
    J Clin Oncol 34:588-96. 2016
    ..The aim of this study was to prospectively determine the clinical utility of (68)Ga-DOTATATE positron emission tomography (PET)/computed tomography (CT) in detecting unknown primary and metastatic GEPNETs...
  21. doi request reprint FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for Lateralization
    Dhaval Patel
    Endocrine Oncology Branch, Clinical Research Center, National Cancer Institute, NIH, Building 10 CRC, Room 3 5840, Bethesda, MD, 20892, USA
    World J Surg 40:683-9. 2016
    ..The aim was to determine if 18F-FDG PET/CT scan could identify hyperfunctioning adrenal masses and determine a biological basis for uptake...
  22. doi request reprint miR30a inhibits LOX expression and anaplastic thyroid cancer progression
    Myriem Boufraqech
    Endocrine Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland
    Cancer Res 75:367-77. 2015
    ..Together, our findings establish a critical functional role for miR30a downregulation in mediating LOX upregulation and thyroid cancer progression, with implications for LOX targeting as a rational therapeutic strategy in ATC...
  23. pmc Hyperparathyroidism-jaw tumor syndrome: Results of operative management
    Amit Mehta
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD Geisel School of Medicine at Dartmouth, Hanover, NH
    Surgery 156:1315-24; discussion 1324-5. 2014
    ..The aim of the present study was to determine the optimal operative approach to parathyroid disease in patients with HPT-JT...
  24. pmc Prospective screening in familial nonmedullary thyroid cancer
    Samira M Sadowski
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md Electronic address
    Surgery 154:1194-8. 2013
    ..Approximately 8% of nonmedullary thyroid cancers are familial. The optimal age for screening in familial nonmedullary thyroid cancer (FNMTC) is unknown...
  25. doi request reprint Association of type O blood with pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome
    Allison B Weisbrod
    Endocrine Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Ann Surg Oncol 19:2054-9. 2012
    ..We analyzed the association of ABO blood type with pancreatic neuroendocrine tumors (PNETs) in a high-risk cohort of patients with Von Hippel-Lindau (VHL) syndrome...
  26. pmc Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma
    Meenu Jain
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Cancer 118:5698-708. 2012
    ..Previous genome-wide expression studies have demonstrated the overexpression of interleukin-13 receptor alpha2 (IL13Rα2) in some human malignancies...
  27. doi request reprint Total 18F-FDG PET/CT Metabolic Tumor Volume Is Associated With Postoperative Biochemical Response in Patients With Metastatic Pheochromocytomas and Paragangliomas
    Dhaval Patel
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD Geisel School of Medicine at Dartmouth, Hanover, NH PET Department, Clinical Center, National Institutes of Health, Bethesda, MD Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD
    Ann Surg 263:582-7. 2016
    ....
  28. doi request reprint Preoperative Imaging Features are Associated with Surgical Complications Following Carotid Body Tumor Resection
    David M Straughan
    Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    World J Surg 39:2084-9. 2015
    ..The aim of this study was to evaluate whether clinical factors or preoperative imaging findings can accurately predict perioperative complications...
  29. doi request reprint Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors
    Xavier M Keutgen
    Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
    Surgery 159:311-9. 2016
    ..Nonfunctioning pancreatic neuroendocrine tumors (NFpNET) present with distant metastases in up to 50% of patients. It is unknown whether removal of the primary tumor in patients with NFpNET and metastases is beneficial...
  30. doi request reprint Long-Term Outcome of Bilateral Laparoscopic Adrenalectomy Measured by Disease-Specific Questionnaire in a Unique Group of Patients with Cushing's Syndrome
    Vladimir Neychev
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Ann Surg Oncol 22:699-706. 2015
    ..There are limited data on long-term outcomes after LBA, partly due to the lack of disease-specific tools for the measurement of impact on patients' health and quality of life...
  31. doi request reprint Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma
    Dhaval Patel
    Endocrine Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA
    Ann Surg Oncol 21:3541-7. 2014
    ..The objective of this study was to perform a comprehensive analysis of serum IGF and IGFBP levels and to determine their utility as diagnostic and prognostic biomarkers in ACC...
  32. doi request reprint The presence of SDHB mutations should modify surgical indications for carotid body paragangliomas
    Ryan J Ellis
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA and Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD
    Ann Surg 260:158-62. 2014
    ..The aim of this study was to determine whether the genetic background of the disease should be incorporated into treatment decision making...
  33. pmc Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome
    Allison B Weisbrod
    Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
    J Am Coll Surg 218:163-9. 2014
    ..Currently, there are limited data on the natural history of these tumors and it is difficult to determine which patients require surgical intervention because the risk of metastatic disease cannot be accurately determined...
  34. pmc Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: opportunities for repurposing
    Lisa Zhang
    Endocrine Oncology Section, Surgery Branch, National Cancer Institute, Clinical Research Center, Building 10 CRC, Room 3 3940, 10 Center Drive, MSC 1201, Bethesda, Maryland 20892, USA
    J Clin Endocrinol Metab 97:E319-28. 2012
    ..An alternative approach is the exploitation of clinically used and/or bioactive compounds...
  35. pmc Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted?
    Ryan J Ellis
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Am Coll Surg 217:489-96. 2013
    ....
  36. doi request reprint Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical tria
    Vladimir Neychev
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    BMJ Open 5:e008248. 2015
    ..However, mutation-targeted therapy with sunitinib or everolimus has not been studied in this patient population...
  37. doi request reprint Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome
    Rachel D Aufforth
    Endocrine Oncology Branch R D A S M S, N N, E K, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 Endocrine Surgery Department P R, Christian Medical College, Vellore, India Geisel School of Medicine A M, Hanover, New Hampshire Thoracic and Gastrointestinal Oncology Branch K T M, National Cancer Institute, Bethesda, Maryland and Program in Reproductive and Adult Endocrinology K P, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892
    J Clin Endocrinol Metab 100:4498-504. 2015
    ..Although practice guidelines recommend biochemical and radiological screening every 1-2 years for pheochromocytoma in patients with VHL, there are limited data on the optimal age and frequency for screening...
  38. pmc DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors
    Nesrin S Rechache
    Endocrine Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Clin Endocrinol Metab 97:E1004-13. 2012
    ..It is not known whether there are any DNA methylation alterations in adrenocortical tumors...
  39. pmc Loss of CPSF2 expression is associated with increased thyroid cancer cellular invasion and cancer stem cell population, and more aggressive disease
    Naris Nilubol
    Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
    J Clin Endocrinol Metab 99:E1173-82. 2014
    ..We used 86 PTC samples enriched for aggressive disease (recurrence and mortality) by quantitative RT-PCR (qRT-PCR). In vitro functional studies of the validated gene were performed...
  40. pmc Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease
    Mio Kitano
    Endocrine Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, CRC, 10 Center Drive, Bethesda, MD 20892, USA
    Surgery 150:1122-8. 2011
    ..The aim of our study was to determine the accuracy of (18)F-DOPA and (18)F-FDG to detect PNETs in patients with von Hippel-Lindau disease (vHL)...
  41. doi request reprint Thyroid Cancer and Nonsteroidal Anti-Inflammatory Drug Use: A Pooled Analysis of Patients Older Than 40 Years of Age
    Dhaval Patel
    1 Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    Thyroid 25:1355-62. 2015
    ..A second aim of the study was to determine additional risk or protective factors for thyroid cancer...
  42. doi request reprint Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma
    Kei Satoh
    Endocrine Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA
    Ann Surg Oncol 22:714-20. 2015
    ..The objective was to determine if metabolic tumor volume (MTV), total lesion glycolysis (TLG), and maximum standardized uptake value (SUVmax) could serve as prognostic markers in patients with ACC...
  43. doi request reprint Quantitative reverse transcription polymerase chain reaction-based detection of thyroid-specific gene expression in fine-needle aspirate for thyroid cancer recurrence evaluation: a case report and review of the literature
    Saïd C Azoury
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    Head Neck 37:E165-8. 2015
    ..Despite improved surveillance for patients after total thyroidectomy for cancer, there has yet to be a diagnostic method that detects recurrence with 100% accuracy...
  44. pmc Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity
    Lisa J Zhang
    Endocrine Oncology Branch, Laboratory of Molecular Biology and Bioinformatics Core Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA and Laboratory of Proteomics and Analytical Technologies, Advanced Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA
    Carcinogenesis 36:420-8. 2015
    ..Our data demonstrate that testosterone regulates thyroid cancer progression by reducing tumor suppressor gene expression and tumor immunity. ..
  45. pmc What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism?
    Richard Webb
    Endocrine Oncology Section, Surgery Branch, National Cancer Institute, Bethesda, MD, USA
    Ann Surg Oncol 19:1881-6. 2012
    ..The objective of this study was to determine which AVS criteria most accurately identify patients with unilateral surgical disease and are associated with significant clinical improvement after adrenalectomy...
  46. pmc Should small papillary thyroid cancer be observed? A population-based study
    Naris Nilubol
    Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
    Cancer 121:1017-24. 2015
    ..The objectives of the current study were to analyze thyroid cancer (TC)-related mortality in a population-based cohort and to determine the impact of small PTCs (defined as tumors ≤ 2 cm in greatest dimension) on TC-related mortality...